Product NewsCeNeS announces the publication of an important independent review of its lead product, M6G
Product NewsOxford Biomedica secures agreement with FDA on special protocol assessment for phase III trial of TroVax in renal cancer
Product NewsBioAlliance Pharma starts pivotal Phase III clinical trial in the US of Loramyc® treatment for oropharyngeal candidiasis
Product NewsBioAlliance Pharma démarre une étude clinique pivot de phase III aux Etats-Unis pour le Loramyc® dans le traitement de la candidose oropharyngée
Product NewsClinPhone and HTS Introduce New Memory Enhancing Technique to Improve Reliability of Clinical Trial Results
Product NewsFaust Pharmaceuticals announces Phase IIa clinical trial results for treatment of amyotrophic lateral sclerosis (ALS)
Product NewsUnmet Medical Needs, Positive Regulatory Frameworks and Increased Investments Support Continued Stem Cell Research
Product NewsTopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
Product NewsPowderMed’s Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients
Product NewsTopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsTopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsARDANA’S NOVEL TESTOSTERONE CREAM REMAINS ON TRACK FOR Q4 2007 LAUNCH FOLLOWING PRE-IND MEETING WITH US FDA.
Product NewsGemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis
